Circulating advanced glycation endproducts and long-term risk of cardiovascular mortality in kidney transplant recipients
Clinical Journal of the American Society of Nephrology Sep 25, 2019
Sotomayor CG, Gomes-Neto AW, van Londen M, et al. - In this prospective cohort study, researchers investigated whether a link exists between circulating advanced glycation endproducts (AGEs) and long-term risk of cardiovascular mortality in stable kidney transplant recipients. They also investigated whether inflammatory, oxidative stress and endothelial dysfunction biomarkers mediated such a link. This analysis included 555 kidney transplant recipients (age 51 ± 12 years, 56% men). Participants were observed during a median duration of 6.9 years. Direct associations of Nε-Carboxymethyl]lysine (CML) and Nε-Carboxyethyl]lysine (CEL) levels with cardiovascular mortality were identified. These links were independent of age, diabetes, smoking status, body mass index, eGFR and proteinuria. Nearly 35% of the link of CML and CEL, with cardiovascular mortality, was consistently explained by free thiol groups and soluble vascular cell adhesion molecule-1 in mediation analyses. Overall, an independent association of circulating levels of AGEs with long-term risk of cardiovascular mortality was evident among participants.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries